Coronary Artery Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Each 8% change in ABCA1-mediated efflux is predicted to be associated with a 0.1 mmol/l change in HDL-C. ABCA1 heterozygotes display a greater than threefold increase in the frequency of coronary artery disease (CAD), with earlier onset than unaffected family members.
|
11086027 |
2000 |
Coronary Artery Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
Preliminary data have suggested that coronary artery disease (CAD) is increased in heterozygotes for ABCA1 deficiency.
|
11714841 |
2001 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease.
|
11257260 |
2001 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease.
|
11257261 |
2001 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.
|
11476965 |
2001 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Mutations within the ABCA1 gene are associated with decreased HDL-C, increased triglycerides, and an increased risk of CAD.
|
11238261 |
2001 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.
|
11940086 |
2002 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The association of the R219K polymorphism in the ATP-binding cassette transporter 1 ( ABCA1) gene with coronary heart disease and hyperlipidaemia.
|
12700893 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We explored if polymorphisms in the ABCA1 gene are associated with CAD and variations in plasma lipid levels, especially HDL-C, and whether the associations may depend on ethnicity.
|
12709788 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Novel polypyrimidine variation (IVS46: del T -39...-46) in ABCA1 causes exon skipping and contributes to HDL cholesterol deficiency in a family with premature coronary disease.
|
14576201 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recently, variants in ATP-binding cassette transporter A1 (ABCA1) were demonstrated to be associated with increased level of high density lipoprotein cholesterol (HDL-C) and decreased risk of coronary artery disease (CAD) in Caucasians.
|
12860256 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.
|
12535741 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.
|
12624133 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Patients with Tangier disease have mutations in the gene encoding ABCA1, which result in functionally impaired protein, a marked deficiency in HDL cholesterol, and a high risk of premature CAD.
|
12679198 |
2003 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ABCA1 gene polymorphisms but not haplotypes are involved in the variability of plasma ApoA1 and the susceptibility to coronary artery disease.
|
14962947 |
2004 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In subjects with coronary artery disease (CAD+), the prevalence of FABP-2 54TT genotype was higher (16.5% versus 5.2%) and that of ABCA1 219RK and KK genotypes lower (33.0% versus 51.5%) than in subjects with no CAD.
|
15135251 |
2004 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The multivariate model included 512 men with coronary artery disease from the REGRESS study who were completely genotyped for eight polymorphisms selected in the univariate procedure (ie, APOA1 G(-75)A, ABCA1 C(-477)T, ABCA1 G1051A, APOC3 T3206G, APOE Arg158Cys, LIPC C(-514)T, LPL Asn291Ser and LPL Ser447Stop).
|
15657615 |
2005 |
Coronary Artery Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
ABCA1 predicted HDL (mean, GG = 36.4 mg/dL, AA = 39.2 mg/dL; P = .02) but not CAD (GG 74%, AA 75%; adjusted P = .96, OR = 0.99).
|
16086925 |
2005 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis.
|
15528481 |
2005 |
Coronary Artery Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
ABCA1 gene was initially implicated in Tangier disease and familial hypoalphalipoproteinemia and has been shown to be associated with coronary artery disease and atherosclerosis as well.
|
16009332 |
2005 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ABCA1, as seen in Tangier disease, result in accumulation of cellular cholesterol, reduced plasma high-density lipoprotein cholesterol, and increased risk for coronary artery disease.
|
16704350 |
2006 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The ATP-binding cassette transporter A1 (ABCA1) mediates reverse cholesterol transport, polymorphisms have been shown to influence the levels of cholesterol and of HDL and the risk of coronary artery disease.
|
16596262 |
2006 |
Coronary Artery Disease
|
0.200 |
Biomarker
|
disease |
BEFREE |
These results suggest that defective ABCA1 function in cholesterol-loaded macrophages is one potential contributor to the impaired RCT process and the increased coronary heart disease risk in subjects with familial low HDL.
|
17372331 |
2007 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We examined common promoter and non-synonymous coding polymorphisms in relation to age of symptom onset in a group of CAD patients (n = 1164), and also carried out in vitro assays to test effects of the promoter variations on ABCA1 promoter transcriptional activity and effects of the coding variations on ABCA1 function in mediating cellular cholesterol efflux.
|
17412755 |
2007 |
Coronary Artery Disease
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
We examined common promoter and non-synonymous coding polymorphisms in relation to age of symptom onset in a group of CAD patients (n = 1164), and also carried out in vitro assays to test effects of the promoter variations on ABCA1 promoter transcriptional activity and effects of the coding variations on ABCA1 function in mediating cellular cholesterol efflux.
|
17412755 |
2007 |